Objective:

To explore the significance of choroidal thickening in relation to axial length reduction and its implications for long-term myopia treatment success.

Key Findings:

• Choroidal thickening does not consistently correlate with the magnitude of axial length reduction, indicating the need for caution in interpretation.
• AL shortening due to choroidal thickening may be a temporary response rather than a true halt in myopia progression, necessitating further monitoring.
• Factors such as systemic blood pressure, physical activity, and hormonal changes can significantly affect choroidal thickness, complicating treatment assessments.

Interpretation:

Clinicians should exercise caution when interpreting axial length measurements during initial treatment, as early reductions may not indicate sustained treatment success and could mislead clinical decisions.

Limitations:

• Limited studies validating the agreement between choroidal thickness measurements and axial dimensions raise concerns about the reliability of direct comparisons.
• Variability in measurement accuracy due to diurnal changes, patient positioning, and equipment calibration can significantly impact clinical assessments.

Conclusion:

Choroidal thickening may create a misleading impression of treatment success; thus, axial length reduction should be evaluated alongside other influencing factors to ensure accurate treatment assessments.